Health Benefits and Risk Reductions Associated with GLP-1 Medications Health Benefits and Risk Reductions Associated with GLP-1 Medications Kidney and Liver Health Improvements The FLOW trial demonstrated 24% reduction in major kidney disease events among patients with type 2 diabetes and chronic kidney disease ^39
The FDA, EMA, or any regulatory authority for human therapeutic use, diagnosis, treatment, or supplementation does not approve it
Nature 393 , 333339 (1998)
Mutual anti-oxidative effect of gossypol acetic acid and gossypol-iron complex on hepatic lipid peroxidation in male rats
News Release February 09, 2012 Probiotics grow in popularity but don't always deliver on promises says ConsumerLab.com -- New report provides guidance to consumers White Plains, New York, February 9, 2012 Probiotic supplements and foods containing "friendly" bacteria or yeast have become popular options for people hoping to improve bowel function or boost immunity
Psychological effects, including anxiety and mood swings, have also been reported, further complicating the overall impact of the substance on users' health